Waters this week reported that its first-quarter revenues jumped 16 percent year over year, to $427.6 million from $367.7 million in the first quarter of 2010.

The rise was driven "by the continued rapid uptake" of the company's Acuity H-Class UPLC and Xevo mass spectrometry systems, President and CEO Douglas Berthiaume said in a conference call following the earnings release, adding that LC and mass spec instrument sales both grew at rates of over 20 percent.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.